• Latest Posts

An Imperial College Based Start-Up Has Raised €27M in Series A for a Blood Cancer Drug

Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors

Jonhson&Jonhson hurries up Genmab’s myeloma treatment

MorphoSys is safe and sound after the promising results of Celgene’s dumped project

ADVERTISEMENT